Abstract: Hypercholesterolemia induces increased transcytosis and accumulation of plasma lipoproteins in the arterial intima, where they interact with matrix proteins and become modified and reassembled lipoproteins. Chondroitin 6-sulfate-modified LDL (CS-mLDL) induces migration, proliferation, and lipid accumulation in human aortic smooth muscle cells (SMCs). To search for the mechanism(s) responsible for lipid accumulation, cultured SMC and macrophages were exposed to CS-mLDL, minimally modified LDL (mmLDL), and native LDL (as a control). Then the cellular uptake, degradation and expression of the LDL receptor (LDL-R) was determined using radioiodinated ligands, ACAT activity assay, fluorescence microscopy and RT-PCR. The uptake of CS-mLDL was 2-fold higher in SMC and 3-to 4-fold higher in macrophages as compared to LDL and mmLDL; the lysosomal degradation of CS-mLDL was slower in SMCs and considerably diminished in macrophages. Compared with LDL, CSmLDL induced increased synthesis and accumulation of esterified cholesterol in SMCs (∼2-fold) and macrophages (∼10-fold) within an expanded acidic compartment. CS-mLDL and mmLDL down-regulate the gene expression of the LDL-R in the both cell types. Mechanisms of CSmLDL-induced lipid accumulation in SMC and macrophages involve increased cellular uptake, and diminished cellular degradation that stimulates cholesterol ester synthesis and accumulation in cytoplasmic inclusions and in the lysosomal compartment in an undegraded form; modified lipoproteins induce down-regulation of LDL-R.
Introduction
The inception of atherogenesis is marked by a sequence of events that start with enhanced transcytosis of plasma lipoproteins across the endothelium, followed by intimal deposition of chemically modified and reassembled lipoproteins (MRL) within the extracellular matrix. MRL contribute to endothelial cell dysfunction, manifested by the production of chemoattractants and adhesion molecules that are instrumental in monocyte recruitment and diapedesis in the subendothelium, whereupon activation become macrophages that avidly take up MRL and turn into foam cells. Similarly, smooth muscle cells (SMCs) migrate to the intima, accumulate lipids and become foam cells. The hallmark of atherosclerotic lesions is the presence of lipid-filled cells (foam cells) derived from macrophages and SMCs [1, 2] .
Under normal conditions, lipoproteins (Lp) are taken up by the cells by receptormediated endocytosis and are delivered to lysosomes where, at acidic pH, the protein and lipid components are degraded. Within the lysosome the cholesteryl esters of Lp are hydrolyzed by acid cholesterol esterase, and the excess free cholesterol is transported to the endoplasmic reticulum where it is reesterified by acyl-CoA:cholesterol acyltransferase (ACAT). The resulting cholesteryl esters are then stored in cytoplasmic inclusions where they may be continually hydrolyzed by a neutral cholesterol esterase and reesterified by ACAT [3] .
In early fatty streaks of some species, cholesteryl esters accumulate in cytoplasmic inclusions whereas in the advanced atherosclerotic lesions the lipids are stored predominantly in lysosomes [4] [5] [6] . The intralysosomal lipid deposition aggravates the atherosclerotic plaque, since the lysosomal lipids are not as easily cleared through cholesterol efflux pathways as those found in cytoplasmic inclusions [7] [8] [9] . It has been reported that oxidized LDL and mildly oxidized LDL determine accumulation of cholesterol and cholesteryl ester in lysosome due to an impaired lysosomal degradation [10] [11] [12] [13] .
LDL has a high affinity for chondroitin sulfate proteoglycan that may interfere in their oxidation [14] . In previous work, we showed that LDL modified by incubation with chondroitin 6-sulfate (CS-mLDL) displayed features similar to modified lipoproteins found in atherosclerotic lesions and had a small content of lipid peroxides. Moreover, CS-mLDL was taken up and led to lipid loading of human aortic SMCs in culture [15] . This study focuses on the mechanism(s) and processes by which CS-mLDL lead to cholesteryl ester accumulation in cytoplasmic inclusion or/and in lysosomes of SMCs and macrophages. To this purpose, we investigated: (1) the cellular uptake and degradation of CS-mLDL, (2) the process of lipoprotein-derived cholesterol esterification, (3) the cholesteryl ester accumulation in lysosome, and (4) the effect of CS-mLDL-derived cholesterol on downregulation of the LDL receptor (LDL-R). The effect of CS-mLDL was compared to that of native LDL and minimally modified LDL. We offer evidence that the mechanisms of foam cell formation derived from SMCs and macrophages reside, at least in part, in the increased uptake and diminished degradation of modified LDL, which generates an accumulation of esterified cholesterol and down-regulation of LDL receptors.
Experimental procedures

Reagents
Special reagents were purchased from the following sources:
125 I-Na and 1-14 C-oleic acid from NEN, Life Science Products, Belgium; Glass Max RNA microisolation-spin cartridge system from Gibco; Titan one tube reverse transcription polymerase chain reaction (RT-PCR) system from Boehringer Mannheim; Nile Red, and LysoSensor Yellow/Blue DND-160 from Molecular Probes; bicinchoninic acid (BCA) kit, chondroitin sulfate C from shark cartilage, Dulbecco's modified Eagle's medium (DMEM), trypsin, delipidated serum, phorbol 12-myristat-13 acetate (PMA) as well as all other chemicals were purchased from Sigma.
Lipoproteins
The LDL fraction was separated from the serum of healthy subjects by density gradient ultracentrifugation at d = 1.019-1.063 g/ml as in [16] . Isolated LDL was dialyzed against 5mM Tris buffer (pH 7.4) for 18 h at 4
• C and passed through a 0.22-μm sterile filter.
Chondroitin-6 sulfate-modified LDL (CS-mLDL) was obtained by incubation of native LDL (in sterile conditions) with chondroitin 6-sulfate (CS) from shark cartilage (Sigma) using 0.5mg protein LDL and 50 μg CS, at 37
• C for 48 h, in the absence of antioxidants.
Incubation was performed in 5mM Tris buffer, pH 7.4, supplemented with 4 mM CaCl 2 , 2 mM MgCl 2, penicillin (50 U/ml), streptomycin (50 g/ml), and neomycin (25 μg/ml) [15] . As a control, LDL was kept in the same conditions as above, except that CS was omitted; this slightly modified LDL was used as minimally modified LDL (mmLDL).
Culture of human aortic smooth muscle cells (SMCs)
Human aortic smooth muscle cell line (ICBP-IM) was obtained by explantation from the media of a fetal thoracic aorta. The cells were grown in Dulbecco's modified Eagle's medium (DMEM) from Sigma supplemented with nonessential amino acids, ascorbic acid (5 mg/ml), penicillin (100 U/ml), streptomycin (100 μg/ml), neomycin (50 μg/ml), HEPES (10mM), and 10 % (v/v) fetal calf serum (FCS). Cultured SMCs were kept at 37
• C with 5 % CO 2 in the air, at relative humidity of 95-97 % and were used between the third and sixth passages.
2. monoiodotyrosine released in culture medium [18] using the technique reported in [19] . Briefly, the culture medium (0.5 ml) was mixed with 100 μl BSA (10 mg/ml) and 200 μl 50 % TCA and the precipitated protein was separated by microfugation (5 min, 12.000×g). Then 250 μl of 5 % AgNO 3 was added to 0.5 ml of the supernatant to precipitate free iodide. After microfugation (as above), the 125 I-TCA soluble material in the supernatant was determined with a gamma counter. The cell protein was assessed by BCA kit. Parallel wells without cells were included as controls for nonspecific adsorption and degradation.
ACAT activity assay
Confluent SMCs, grown in 24-well plates were incubated for 48 h with CS-mLDL, mmLDL, or native LDL (100 μg cholesterol/ml) in the presence of 14 C-oleat-albumin, at final oleat concentration of 0.27 mM with specific activity 4,000-5,000 cpm/nmol oleat as in [20] . Cellular lipids extracted with hexan / isopropanol (3:2) were separated by thin layer chromatography (TLC) in a solvent containing heptan -dietyl ether -acetic acid (85:15:2). 14 C-Cholesteryl ester was counted in a Beckman LS8100 scintillation counter. The cell protein was assessed by BCA kit in 0.2 N NaOH extract. 1-14 C-oleic acid was purchased from NEN, Life Science Products, Belgium.
Determination of cellular cholesterol
SMCs seeded in 6-well plates (2×10 5 cells/well) were grown for 3-4 days to attain confluence. U937 cells placed into 6-well plates (6×10 5 cells/well) were activated with PMA for 4 days. After incubation for 24 h in DMEM containing 0.2 % FCS, the cells were exposed to native and modified lipoproteins (100 μg cholesterol/ml) for 48 h. In the lipid extract obtained as described above, total and free cholesterol were quantified by a fluorimetric method as previously reported [21] . Esterified cholesterol was calculated as the difference between total and free cholesterol and relative to oleat cholesterol standard curve. Total, free, and esterified cholesterol were expressed as a function of cellular protein extracted in 0.2 N NaOH and assessed by BCA kit.
Visualization of lipid loading
SMCs and U937 macrophages seeded on coverslips in 24-well plates (as described above) were exposed to native and modified lipoproteins (100 μg cholesterol/ml) for 48 h. Afterwards, the cell lipids were stained with 150 ng/ml Nile red (Molecular Probes) in PBS (5 min) then the coverslips were washed with PBS and mounted on slides in 20 % glycerol in PBS. Nile red fluorescence was observed with a Microphot SA Nikon microscope using filter set for fluorescein (λex=420-490 nm, λem>520 nm) [22] .
Lysosome activity assay
The cells (SMCs and macrophages) were plated on coverslips, in 24-well plates and incubated with the probes for 48 h, as described above. After washing with DMEM, the cells were exposed to LysoSensor Yellow/Blue DND-160 (Molecular Probes), i.e., 8 μM in appropriate culture medium, for 5min, at 37
• C, washed with PBS without Ca and Mg, mounted on slides in 20 % glycerol in PBS and observed by fluorescence microcopy. A fluorescein filter set for LysoSensor yellow/blue in acidic environment (λex=420-490 nm, λem>520 nm) and a blue filter set (λex=365 nm, λem=450 nm) for LysoSensor at pH≥ 6 were used.
Determination of LDL receptor gene expression by semiquantitative reverse transcriptase -PCR
The cells seeded in 50-mm plates at a density 4×10 5 cells/plate for SMCs, and 1×10 6 cells/ plate for monocytes were allowed to grow or differentiate and were then preincubated in appropriate medium with 5 % delipidated serum for 24 h. CS-mLDL, mmLDL, or native LDL (100 μg cholesterol/ml) were added to the culture medium and after 24 h, the cells were washed and total RNA was isolated using Glass Max RNA microisolation spin cartridge system (Gibco). The total RNA (0. 
Statistical analyses
The data obtained in various experimental conditions were statistically compared by analysis of variance (one-way ANOVA). Differences among means were considered significant when P<0.05. Data are presented as mean ±SEM.
Results
Uptake and degradation of 125 I-CS-mLDL by SMCs and macrophages
In these experiments, the total cellular uptake of each radioiodinated lipoprotein was considered the sum of internalized (undegraded) lipoprotein (i.e., the radioactivity retained by the cells) and the degraded lipoprotein released in the culture medium as monoiodotyrosine. The ratio between the degraded probe and the internalized probe was the indicator of intralysosomal degradation rate of the lipoproteins. The results showed that upon incubation of SMCs with various concentrations (10, 25, and 100 μg protein/ml) of radiolabeled LDL, mmLDL, and CS-mLDL, the uptake of 125 I-CS-mLDL was about 2-fold higher than that of native 125 I-LDL or 125 I-mmLDL (Fig. 1A) .
The cellular lysosomal degradation of native and modified lipoproteins estimated using the ratio between degraded/internalized protein gave a ratio for 125 I-CS-mLDL that was approximately half of the value obtained for native or mmLDL (Fig. 1B) . These data suggested that the degradation of CS-mLDL was slower than that of native or mmLDL. Macrophages exposed in culture to increasing concentrations of radiolabeled native or modified lipoproteins took up 125 I-CS-mLDL more avidly (3-to 4-fold) than 125 I-LDL or 125 I-mmLDL (Fig. 1C) . At the same time, the rate of lysosomal degradation of CSmLDL was considerably lower at all concentrations used (Fig. 1D) . The degradation of LDL was higher than that of mmLDL and was lower at 100 μg than at 25 μg protein/ml concentration. By comparison, the degradation rate of LDL and modified lipoproteins was lower in macrophages than in SMCs (Figs. 1B, D) . 
Effect of CS-mLDL on cholesterol esterification in SMCs
In SMCs, to determine whether incubation with different lipoproteins induces esterification of lipoprotein-derived cholesterol to cholesteryl ester, the ACAT activity in the presence of 14 C-oleat was assessed. As shown in Fig. 2 , native LDL and mm LDL stimulated cholesteryl ester synthesis in SMCs about 3-to 4-fold more than that of controls (experiments done in the same conditions except that the lipoprotein probes were omitted). In the case of CS-mLDL -despite the fact that the probe was taken up vigorously by SMCs (Fig. 1A) -the stimulation of cholesteryl ester synthesis was lower (by ∼ 30 %) than that determined for native or mmLDL (Fig. 2) . 
Effect of CS-mLDL on accumulation of cholesterol in SMCs and macrophages
SMCs and macrophages incubated with native and modified lipoprotein accumulated a significant amount of cholesterol within the cells. The total cholesterol quantity was a function of the lipoprotein modification; in all cases, an increase of free cholesterol and a significant accumulation of cholesterol esters, was observed (Figs. 3A, B ). Upon incubation with native or modified lipoproteins (at the equivalent quantity of cholesterol), the accumulation of esterified cholesterol in SMCs was approximately 2-fold higher for the cells incubated with CS-mLDL than with native or mm-LDL (Fig. 3A) . These data were surprising since the high content of cholesteryl esters in SMCs incubated with CS-mLDL differs from the results obtained on cholesteryl ester synthesis in the presence of 14 C-oleat (Fig. 2) . This discrepancy can be explained by the fact that esterified cholesterol may be present both, in cytoplasmic inclusion (derived by cholesterol esterification) and in the endosome-lysosome compartment as esterified cholesterol retained in an undegraded form. This assumption correlates well with the slower degradation of CS-mLDL by SMCs (Fig. 1B) . It should be mentioned that the cells incubated with LDL, mmLDL, or CS-mLDL exhibited the same quantity of free cholesterol, higher than in control cells (Fig. 3A) .
(A) (B) Fig. 3 Accumulation of esterified cholesterol by SMCs (A) and macrophages (B) exposed to LDL, mmLDL, and CS-mLDL (100 μg cholesterol/ml) for 48 h. Total and free cholesterol of lipid extracts was quantified by fluorimetry (see Methods). Esterified cholesterol was calculated by the difference between total and free cholesterol. Results are from four experiments. Note the significantly higher effect on esterified cholesterol deposition in cells in the presence of CS-mLDL as compared to native and mmLDL.
Macrophages incubated in conditions similar to SMCs, exhibited the highest cholesteryl ester content when exposed to CS-mLDL. Values were almost 3-fold above those obtained when cells were incubated with mmLDL, and 10-fold above those attained when macrophages were exposed to LDL (Fig. 3B) . Considering the slower degradation rate of CS-mLDL by macrophages, we assumed that part of the esterified cholesterol is present in an undegraded form in the endosome-lysosomal compartment.
Expansion of endosome-lysosome compartment associated with cholesterol accumulation
To visualize the effect of native and modified lipoproteins on the accumulation of cytoplasmic lipids and to reveal whether modifications of the lysosomal compartment occur, SMCs and macrophages incubated with CS-mLDL, mmLDL, LDL, and controls (in the absence of any probe) were exposed to LysoSensor (a pH-sensitive fluorescent marker). This marker exhibits a pH-dependent dual-emission spectra in living cells: in acidic organelles it has predominantly a yellow-green fluorescence, and in less acidic organelles it displays a blue fluorescence. As shown in Fig. 4A , SMCs incubated with native and modified lipoproteins and stained with LysoSensor, exhibited an expansion of the acidic compartment. This appeared as an increased number of fluorescent dots (vesicles) compared to controls; the fluorescent vesicles were localized mainly at the cell periphery. Moreover, in the case of cells incubated with CS-mLDL, the lysosomal compartment was more extended in volume compared with native and mmLDL (Fig. 4A) .
Nile red staining of intracellular lipid droplets revealed that incubation of SMCs with native and mmLDL induced an increase in the number of cytoplasmic lipid droplets; their number was slightly higher in the case of mmLDL (Fig. 4B) . Exposure of SMCs to CSmLDL generated an increase in the number and size of lipid droplets seemingly spread all over the cytoplasm (Fig. 4B) . In all cases, the localization of lipid droplets differed from that of the acidic compartment (Figs. 4A, B) .
Macrophages incubated with lipoproteins and further exposed to the fluorescent LysoSensor, exhibited an increase in the acidic compartment as a function of the modified lipoprotein employed. Thus, compared to controls, there were few acidic compartments in the case of LDL, a slight increase was found when cells were incubated with mmLDL, whereas upon incubation with CS-mLDL the yellow-green fluorescence was scattered throughout the cytoplasm, depicting a significant increase in the acidic compartments (Fig. 4C) . The number of intracellular lipid droplets visualized by Nile red staining, was higher in the case of LDL and mmLDL than in controls; a strikingly large accumulation of lipid droplets was found in macrophages incubated with CS-mLDL (Fig. 4D) . In SMCs, there was no correspondence found in the localization of the acidic compartment and of the lipid droplets in macrophages (Figs. 4C, D) . ) and macrophages (C, D) incubated with LDL, CS-mLDL, or mmLDL as compared to controls. SMCs and macrophages were exposed to lipoproteins (100 μg cholesterol/ml) and after 24 h the cells were washed, total RNA was isolated, and used as a template for RT-PCR. The PCR products were electrophoresed and stained with ethidium bromide (A, C). The LDL-R mRNA levels were quantified relative to GAPDH mRNA. Data are expressed as histograms in B and D.
LDL and modified lipoprotein regulation of gene expression of LDL receptors (LDL-R) in SMCs and macrophages
To determine whether modified lipoproteins induce regulation of LDL-R in SMCs and macrophages, cells were incubated with LDL, CS-mLDL, or mmLDL (100 μg cholesterol) and after 24 h total RNA was extracted and subjected to semiquantitative RT-PCR (as described in Methods). As a control, the LDL-R expression was assessed in SMCs and macrophages prior to exposure to the probes. The expression of LDL-R mRNA was reported to GAPDH mRNA expression. In SMCs, all probes used (LDL, CS-mLDL, or mmLDL) induced a significant downregulation of the LDL-R expression, compared to controls (Figs. 5A, B) . When the LDL-R mRNA level was determined relative to controls, it was found that for all probes the expression of LDL-R was very low, representing 10-20 % of the control value (Fig.  5B ). However a difference between the three probes was found, i.e., in the case of the SMCs incubated with LDL and mmLDL, the LDL-R expression was reduced to 10 % of the control values whereas when incubated with CS-mLDL the decrease attained only 20 % of the control vale (Fig. 5B ). This may be explained by a delayed down-regulation of LDL-R expression probably as an effect of the slower degradation of CS-mLDL (as shown in Fig. 1B) .
In macrophages, LDL, CS-mLDL, or mmLDL induced a significant down-regulation of the LDL-R comparable to that found in SMCs (Fig. 5C ). When reported to control, it was found that the level of LDL-R mRNA, attained a similar decrease for all native or modified lipoproteins (Fig. 5D) .
Comparison between the expression of LDL-R in SMCs and macrophages indicated some similarities and one difference: in both cases, incubation with lipoproteins reduced the LDL-R expression to 10-20 % of the control value; nevertheless, in SMCs the decrease in LDL-R mRNA was approximately 80-90 % whereas in macrophages this value was only 60-65 % of the control values (Figs. 5B, D) .
Discussion
We previously reported that incubation of LDL with chondroitin 6-sulfate (a major component of matrix proteoglycans) induces morphological and biochemical modifications of the LDL, increasing its atherogenic propensity [15] . The latter is manifested by a stimulatory effect of CS-mLDL on migration, proliferation, and lipid loading of SMCs. The results suggested that in SMCs, uptake of CS-mLDL is dependent, in part, on the LDL receptor. The present study was intended to broaden previous data, on the trail and mechanism(s) of the accumulation of CS-mLDL-derived cholesterol in SMCs and macrophages. Both these cell types turn into foam cells in the developed atheroma.
The mechanisms underlying the formation of SMC-derived foam cell remains unclear. Earlier studies have shown that SMCs incubated with cholesteryl ester-rich droplets derived from lipid-laden macrophages [24] or SMCs cocultured with macrophages incubated with acetylated LDL [25] or with a lipoprotein-proteoglycan complex [26] accumulate lipids by a mechanism involving especially, phagocytosis. It was also reported that SMCs express few scavenger receptors of SR-A type [27] , that LDL-R is subjected to downregulation [28] , and that mRNA expression of LDL-R is low in the intima-media of normal or atherosclerotic NZW rabbits [29] .
In the experiments reported here, LDL, mmLDL, and CS-mLDL down-regulated LDL-R expression in SMCs; however, by comparison, in the case of CS-mLDL, the process was slightly less pronounced than in the case of LDL and mmLDL. These findings could be explained by the slower degradation rate of CS-mLDL in SMCs. Also, they corroborate well with our preliminary experiments that showed that after incubation of SMCs with CS-mLDL for 24 h, the competitive effect of native LDL diminishes as a function of time, indicating that CS-mLDL is able to down-regulate the LDL-R (data not shown).
Upon incubation with CS-mLDL, accumulation of cholesteryl esters in SMCs is 2-fold higher than in the case of LDL and mmLDL (Fig. 3) . Based on the biochemical determinations and the ACAT activity assay, we can safely assume that this accumulation is due in part, to the cholesteryl esters synthesized from CS-mLDL-derived cholesterol and in part to the storage of cholesteryl esters in the endosomal-lysosomal compartment in an undegraded form. This assumption is supported by the expansion of the acidic compartment in SMCs exposed to CS-mLDL, as seen when the specific pH-sensitive fluorescent marker was employed. Our results corroborate well and explain the reported lysosomal lipid accumulation in SMCs in advanced atherosclerotic lesion [5, 6, 30] . They are also in good agreement with reports that showed that cultured SMCs incubated with lipid droplets accumulate lipids in cytoplasmic inclusions and lysosomes [31] ; the presence of cholesteryl esters in lysosomes was attributed to a failure of lysosomal cholesteryl esterase activity [32] .
In the present experimental conditions, uptake of CS-mLDL by U937-macrophages was considerably higher and the degradation was significantly lower than that of LDL and mmLDL (Figs. 1C, D) . These results may explain the high accumulation of cholesteryl esters, i.e., 4-and 10-fold higher than the values obtained for mmLDL and LDL, respectively. Based on the expansion of the acidic compartment (as revealed by LysoSensor marker), one can assume that CS-mLDL-derived cholesteryl esters accumulate in the lysosomal compartment of macrophage where they are stored in an undegraded form.
As in SMCs, the LDL-R in macrophages is down-regulated by CS-mLDL at the same extent as LDL or mmLDL. However, the decrease in LDL-R expression in macrophages attains a value 60-65 % of the control, whereas in SMCs this figure was 80-90 % of the control value. This difference may reflect that (1) the regulation of LDL-R expression in SMCs is tighter than in macrophages, (2) the rate of cholesterol metabolism differs in the two cells, or (3) the mechanism of uptake varies, being predominantly dependent on LDL-R in SMCs and on phagocytosis in macrophages. The latter assumption is supported by the reported increased capacity of U937-macrophages for phagocytosis [33] .
Together, these results indicate that both, SMCs and macrophages, exhibit an increased uptake and an impaired degradation of CS-mLDL that in turn generate an accu-mulation of cholesteryl esters in cytoplasmic inclusions and in lysosomes in an undegraded form. It was previously reported that in macrophages, the inefficient lysosomal degradation could be due to the inhibition of endosome-lysosome fusion [34] , or partial lysosomal enzyme inactivation and relocation [35] or internalization through distinct pathways leading to expansion of the acidic compartment [12] . To determine if similar mechanisms occur in SMCs, further investigations are required.
In conclusion, the results indicate that in SMCs and macrophages (1) the uptake of CS-mLDL is significantly higher than that of LDL or mmLDL; (2) the cellular degradation of CS-mLDL is slow, especially in macrophages, which in turn (3) generates an accumulation of esterified cholesterol; (4) the latter is localized in cytoplasmic inclusions and in the endosomal-lysosomal compartment in an undegraded form; and (5) all modified lipoproteins induce down-regulation of LDL-receptor. These data strengthen and extend the previous results, showing that in addition to the effect on SMC migration and proliferation, CS-mLDL also induces lipid loading in SMCs and macrophages. The data also show that the interaction of LDL with matrix components (such as chondroitin sulfate) enhances the atherogenic propensity of LDL.
